Low birth weight and its association with attention deficit hyperactivity disorder (ADHD) in young children

This study was conducted to understand the association between low birth weight and attention deficit hyperactivity disorder (ADHD) in young children aged 36 – 59 months in Sedayu Subdistrict, Bantul District, Daerah Istimewa Yogyakarta. This study used cross-sectional design with a total of 185 children aged 36 – 59 months were selected by probability proportional to size (PPS) sampling technique. This study was located in Sedayu Subdistrict, Bantul District, Daerah Istimewa Yogyakarta. The study was conducted January 2017. Main variables in this study were low birth weight, prematurity, and attention deficit hyperactivity disorder (ADHD). Maternal and child book was used to confirm the birth weight and gestational age data. Abbreviated Conners Rating Scale form was used to detect ADHD symptoms in young children, followed by a psychologist confirmation. Data were analyzed by using descriptive statistics, chi-square test, and multiple logistic regression at 0.05 level of significance. The proportion of attention deficit hyperactivity disorder (ADHD) was 29.2% in this study. Meanwhile, the prevalence of low birth weight (<2500 g) was 8.11% and prematurity (<37 weeks gestational age) was 2.16%. Children with birth weight less than 2500 g were more likely to develop ADHD symptoms (OR: 3.2; 95%CI: 1.09-9.48) compared to children with normal birth weight. On the other hand, prematurity was not associated with ADHD (OR: 0.64; 95%CI: 0.06-6.89). This study concluded that low birth weight was associated with attention deficit hyperactivity disorder (ADHD). However, prematurity was not related significantly with ADHD. Efforts are needed in improving nutrition adequacy for infants and young children, also development stimulation, especially for those born with low birth weight.

Download Full-text

EARLY RECOGNIZATION OF THE CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER BY VANDERBILT ADHD RATING SCALE FOR TEACHERS AND PARENTS

Journal of Medicine and Pharmacy ◽

10.34071/jmp.2019.4.12 ◽

2019 ◽

pp. 85-91

Author(s):

Dinh Duong Le ◽

Van Thang Vo ◽

Thi Mai Nguyen ◽

Thi Han Vo ◽

Huu Chau Duc Nguyen ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

High Risk ◽

Attention Deficit ◽

Primary Schools ◽

Rating Scale ◽

Cross Sectional Study ◽

Cross Sectional ◽

Hyperactivity Disorder ◽

Teachers And Parents ◽

Key Words Adhd

Objectives: The study aims to explore the prevalence of attention deficit hyperactivity disorder and to examine the associated factors with ADHD among primary students by Vanderbilt ADHD rating scale for teacher and parents. Methods: A cross-sectional study design was conducted in 564 students who selected randomly in 4 primary schools in Hue city. Vanderbilt ADHD rating scale for parents and teachers were applied to evaluate the ADHD of children over 6 months ago. Results: The overall prevalence of children who had high risk with ADHD was 4.1% (95%CI: 2.44 - 5.72), including 4.6% and 4.8% in the rating of teachers and parents, respectively. Male was more likely to have ADHD than female (OR adj: 4.64 (95%CI: 1.53 - 14.05) and lack of closely friend (OR adj: 5.11 (95% CI: 2.13 - 12.24). Conclusion: Vanderbilt ADHD diagnosis rating scale for teachers and parents can be used to early recognization children with a high risk of ADHD. Key words: ADHD, Vanderbilt, ratings scale, teacher, parent, children

Download Full-text

Impact of Low Birth Weight on Attention-Deficit Hyperactivity Disorder

Journal of Developmental & Behavioral Pediatrics ◽

10.1097/00004703-200202000-00004 ◽

2002 ◽

Vol 23 (1) ◽

pp. 16-22 ◽

Cited By ~ 173

Author(s):

ERIC MICK ◽

JOSEPH BIEDERMAN ◽

JEFFERSON PRINCE ◽

MARIANNA J. FISCHER ◽

STEPHEN V. FARAONE

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Birth Weight ◽

Low Birth Weight ◽

Attention Deficit ◽

Hyperactivity Disorder

Download Full-text

Atomoxetine versus Methylphenidate in Paediatric Outpatients with Attention Deficit Hyperactivity Disorder: A Randomized, Double-Blind Comparison Trial

Australian & New Zealand Journal of Psychiatry ◽

10.1080/00048670601057767 ◽

2007 ◽

Vol 41 (3) ◽

pp. 222-230 ◽

Cited By ~ 57

Author(s):

Yufeng Wang ◽

Yi Zheng ◽

Yasong Du ◽

Dong H. Song ◽

Yee-Jin Shin ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Rating Scale ◽

Response Rates ◽

Double Blind Study ◽

Adhd Symptoms ◽

Double Blind ◽

Hyperactivity Disorder ◽

End Point ◽

Blind Comparison

Objective: To (i) test whether atomoxetine is non-inferior to methylphenidate in treating symptoms of attention deficit hyperactivity disorder (ADHD) in paediatric patients; and (ii) determine the tolerability of the two drugs. Method: This double-blind study was conducted in 6- to 16-year-old outpatients with ADHD (DSM-IV) in China, Korea and Mexico (January–October 2004). Patients were randomly assigned to once-daily atomoxetine (0.8–1.8 mg kg−1 day−1; n = 164) or twice-daily methylphenidate (0.2–0.6 mg kg−1 day−1; n = 166) for ∼8 weeks. Primary efficacy assessment was the comparison of response rates (≥40% reduction from baseline to end point in total score) on the Attention Deficit Hyperactivity Disorder Rating Scale-IV-Parent Version: Investigator-Administered and -Scored. Tolerability measures included, but were not limited to, the assessment of treatment-emergent adverse events (TEAEs) and weight. Results: Atomoxetine was non-inferior to methylphenidate in improving ADHD symptoms based on response rates (atomoxetine, 77.4%; methylphenidate, 81.5%; one-sided 95% lower confidence limit = −11.7%, p = 0.404). Treatment-emergent adverse effects experienced significantly more frequently in the atomoxetine group, compared with the methylphenidate group, included anorexia (37.2% vs. 25.3%; p = 0.024), nausea (20.1% vs. 10.2%; p = 0.014), somnolence (26.2% vs. 3.6%; p <0.001), dizziness (15.2% vs. 7.2%; p = 0.024) and vomiting (11.6% vs. 3.6%; p = 0.007), most of which were of mild or moderate severity. Atomoxetine-treated patients experienced a small but significantly greater mean weight loss from baseline to end point than methylphenidate-treated patients (−1.2 kg vs. −0.4 kg; p <0.001). Conclusions: This study suggests that atomoxetine is non-inferior to methylphenidate in the improvement of ADHD symptoms in paediatric outpatients. Although both of the drugs were well tolerated, atomoxetine was associated with a higher incidence of TEAEs than methylphenidate.

Download Full-text

Incidence of Internet addiction in adult attention deficit hyperactivity disorder

European Psychiatry ◽

10.1016/j.eurpsy.2017.02.457 ◽

2017 ◽

Vol 41 (S1) ◽

pp. S396-S397

Author(s):

B. Tuzun Mutluer ◽

T.G. Yener Orum ◽

S. Sertcelik

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Internet Addiction ◽

Attention Deficit ◽

Internet Use ◽

Adult Adhd ◽

Rating Scale ◽

Self Report ◽

Adhd Symptoms ◽

Hyperactivity Disorder ◽

Dsm Iv

ObjectiveIn this study, it was aimed to determine the internet use properties of Adult Attention Deficit Hyperactivity Disorder (ADHD) patients who were followed-up at Haydarpasa Numune Research and Training Hospital, Psychiatry Department; ADHD Outpatient Clinic.MethodThirty participants who were diagnosed with adult ADHD aged between 18–31 years rated their ADHD symptoms in childhood retrospectively, using Wender Utah Rating Scale. Patients rated current adult ADHD symptoms with the Adult ADHD DSM-IV-Based Diagnostic Screening and Rating Scale (DSRS) and severity of symptoms measured by Adult ADHD Self-Report Scale (ASRS). Internet addiction (IA) was assessed with Young's Internet Addiction Scale (IAS). It was determined that, none of 30 Adult ADHD patients have been diagnosed with IA.29 of patient have moderate internet use although 1 of patients have risky internet use. The results revealed that total ASRS score (P = 0.020), total Adult ADHD DSM-IV-Based DSRS score (P = 0.036) and the Attention Deficit related properties subscale total score (P = 0.042) were significantly correlated with the IAS total score. Subscale of the self-report scales including; failing to finish schoolworks, chores, or duties at workplace, difficulty of following through on instructions (P = 0.017), restiveness; impaired inhibitory performance (P = 0.017), feeling not confident (P = 0.017), difficulty of managing time (P = 0.047), failing to give close attention to details or making careless mistakes (P = 0.037) are closely relevant to IAS total score.ResultIn conclusion, clinical features, which are characteristic of Adult ADHD could have same shared etiology with IA. Furthermore, ADHD patients are more likely to have an IA diagnosis. However, it was thought that this result had to be supported with studies including larger samples.Disclosure of interestThe authors have not supplied their declaration of competing interest.

Download Full-text

The Association between Excessive Internet Gaming Behavior and Immersive Tendency, Mediated by Attention Deficit/Hyperactivity Disorder Symptoms, in Korean Male University Students

Psychiatry Investigation ◽

10.30773/pi.2019.0173 ◽

2020 ◽

Vol 17 (5) ◽

pp. 403-411

Author(s):

Dooyoung Jung ◽

Eun-jung Shim ◽

Hyeonggyu Park ◽

Kwanglo Lee ◽

Sangil Lee ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Undergraduate Students ◽

Attention Deficit ◽

Adhd Symptom ◽

Internet Gaming Disorder ◽

Mediation Effect ◽

Adhd Symptoms ◽

Cross Sectional ◽

Hyperactivity Disorder ◽

Internet Gaming

Objective Problematic online gaming (POG) and problematic Internet use (PIU) have become a serious public mental health problem, with Internet gaming disorder (IGD) included in “Conditions for further study” section of DSM-5. Although higher immersive tendency is observed in people affected by POG, little is known about the simultaneous effect of immersive tendency and its highly comorbid mental disorder, attention deficit/hyperactivity disorder (ADHD). This study aimed to assess the relationship between immersive tendency, ADHD, and IGD.Methods Cross-sectional interview study was conducted in Seoul, Korea with 51 male undergraduate students; 23 active gamers and 28 controls.Results Current ADHD symptoms showed partial mediation effect on the path of immersive tendency on POG and PIU. The mediation model with inattention explained variance in both POG and PIU better than other current ADHD symptom models (R<sup>2</sup>=69.2 in POG; 69.3 in PIU). Childhood ADHD symptoms models demonstrated mediation effect on both POG and PIU which explained less variance than current ADHD symptom models (R<sup>2</sup>=53.7 in POG; 52.1 in PIU). Current ADHD symptoms, especially inattention, appear to mediate the effect of immersive tendency on POG/PIU.Conclusion Immersive tendencies may entail greater susceptibility to IGD, and comorbidity with ADHD may mediate the effect of immersive tendency on IGD.

Download Full-text

Aripiprazole in Juvenile Bipolar Disorder Comorbid with Attention-Deficit/Hyperactivity Disorder: An Open Clinical Trial

CNS Spectrums ◽

10.1017/s1092852900015443 ◽

2007 ◽

Vol 12 (10) ◽

pp. 758-762 ◽

Cited By ~ 24

Author(s):

Silzá Tramontina ◽

Cristian Patrick Zeni ◽

Gabriel Ferreira Pheula ◽

Carla Ketzer de Souza ◽

Luis Augusto Rohde

Keyword(s):

Bipolar Disorder ◽

Attention Deficit Hyperactivity Disorder ◽

Children And Adolescents ◽

Attention Deficit ◽

Rating Scale ◽

Response To Treatment ◽

Adhd Symptoms ◽

Young Mania ◽

Global Functioning ◽

Hyperactivity Disorder

ABSTRACTIntroductionJuvenile bipolar disorder (JBD) is a highly impairing chronic mental health condition that affects children and adolescents' overall functioning. Comorbidity with attention-deficit/hyperactivity disorder (ADHD) is extremely prevalent and may determine worse response to treatment. Few investigations have addressed the use of recent atypical antipsychotics in JBD, although several guidelines suggest their use.MethodsWe conducted a 6-week open trial with aripiprazole in 10 children and adolescents with JBD comorbid with ADHD to assess impact on mania and ADHD symptoms, respectively, by means of the Young Mania Rating Scale and the Swanson, Nolan and Pelham Scale, as well as on global functioning (Clinical Global Impressions–Severity), and adverse events.ResultsSignificant improvement in global functioning scores (F=3.17, P=.01, effect size=0.55), manic symptoms (F=5.63, P<.01; ES=0.93), and ADHD symptoms (t=3.42, P<.01; ES=1.05) were detected. Although an overall positive tolerability was reported, significant weight gain (F=3.07, P=.05) was observed.ConclusionAripiprazole was effective in improving mania and ADHD symptoms, but neither JBD nor ADHD symptom remission was observed in most of the cases. Randomized placebo-controlled trials for JBD and ADHD are needed.

Download Full-text